1887

Abstract

Purpose. This study investigated the HPIV3 circulating strains in Croatia and whether the other parts of HPIV3 genome (F gene and HN 582 nucleotides fragment) could be equally suitable for genetic and phylogenetic analysis.

Methodology. Clinical materials were collected in period 2011–2015 from children suffering from respiratory illnesses. In positive HPIV3 samples viral genome was partially amplified and sequenced for HN and F genes. Obtained sequences were analysed by phylogenetic analysis and genetic characterization was performed.

Results. All samples from this study belonged to subcluster C and over a short period of time, genetic lineage C3a gained prevalence over the other C genetic lineages, from 39 % in 2011 to more than 90 % in 2013 and 2014. Phylogenetic classifications of HPIV3 based on the entire HN gene, HN 582 nt fragment and entire fusion (F) gene showed identical classification results for Croatian strains and the reference strains. Molecular analysis of the F and HN glycoproteins, showed their similar nucleotide diversity (Fcds P=0.0244 and HNcds P=0.0231) and similar Ka/Ks ratios (F Ka/Ks=0.0553 and HN Ka/Ks=0.0428). Potential N-glycosylation sites, cysteine residues and antigenic sites are generally strongly conserved in HPIV3 glycoproteins from both our and the reference samples.

Conclusion. The HPIV3 subclaster C3 (genetic lineage C3a) became the most detected circulating HPIV3 strain in Croatia. The results indicated that the HN 582 nt and the entire F gene sequences were as good for phylogenetic analysis as the entire HN gene sequence.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000459
2017-04-28
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/4/502.html?itemId=/content/journal/jmm/10.1099/jmm.0.000459&mimeType=html&fmt=ahah

References

  1. Goya S, Mistchenko AS, Viegas M. Phylogenetic and molecular analyses of human parainfluenza type 3 virus in Buenos Aires, Argentina, between 2009 and 2013: the emergence of new genetic lineages. Infect Genet Evol 2016; 39: 85– 91 [CrossRef] [PubMed]
    [Google Scholar]
  2. Mao N, Ji Y, Xie Z, Wang H, Wang H et al. Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China. PLoS One 2012; 7: e43893 [CrossRef] [PubMed]
    [Google Scholar]
  3. Pancer KW, Gut W, Abramczuk E, Lipka B, Litwińska B. Non-influenza viruses in acute respiratory infections among young children. High prevalence of HMPV during the H1N1V.2009 pandemic in Poland. Przegl Epidemiol 2014; 68: 627– 632 [PubMed]
    [Google Scholar]
  4. Ljubin-Sternak S, Marijan T, Ivković-Jureković I, Čepin-Bogović J, Gagro A et al. Etiology and clinical characteristics of single and multiple respiratory virus infections diagnosed in Croatian children in two respiratory seasons. J Pathog 2016; 2016: 1– 8 [CrossRef] [PubMed]
    [Google Scholar]
  5. Schmidt AC, Schaap-Nutt A, Bartlett EJ, Schomacker H, Boonyaratanakornkit J et al. Progress in the development of human parainfluenza virus vaccines. Expert Rev Respir Med 2011; 5: 515– 526 [CrossRef] [PubMed]
    [Google Scholar]
  6. Zhan X, Slobod KS, Krishnamurthy S, Luque LE, Takimoto T et al. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine 2008; 26: 3480– 3488 [CrossRef] [PubMed]
    [Google Scholar]
  7. Madhi SA, Cutland C, Zhu Y, Hackell JG, Newman F et al. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine 2006; 24: 2432– 2439 [CrossRef] [PubMed]
    [Google Scholar]
  8. Karron RA, Collins PL Jr. Parainfluenza viruses. In Knipe DM, Howley FL. (editors) Fields Virology, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013; pp. 996– 1023
    [Google Scholar]
  9. Fukushima K, Takahashi T, Ueyama H, Takaguchi M, Ito S et al. Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase. FEBS Lett 2015; 589: 1278– 1282 [CrossRef] [PubMed]
    [Google Scholar]
  10. Xu R, Palmer SG, Porotto M, Palermo LM, Niewiesk S et al. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. MBio 2013; 4: e00803–13 [CrossRef] [PubMed]
    [Google Scholar]
  11. Porotto M, Fornabaio M, Kellogg GE, Moscona A. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J Virol 2007; 81: 3216– 3228 [CrossRef] [PubMed]
    [Google Scholar]
  12. Fukushima K, Takahashi T, Ito S, Takaguchi M, Takano M et al. Terminal sialic acid linkages determine different cell infectivities of human parainfluenza virus type 1 and type 3. Virology 2014; 464–465: 424– 431 [CrossRef] [PubMed]
    [Google Scholar]
  13. Xie W, Wen H, Chu F, Yan S, Lin B et al. Mutations in the DI-DII Linker of human parainfluenza virus type 3 fusion protein result in diminished fusion activity. PLoS One 2015; 10: e0136474 [CrossRef] [PubMed]
    [Google Scholar]
  14. Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC et al. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol 2004; 335: 1343– 1357 [CrossRef] [PubMed]
    [Google Scholar]
  15. Yin HS, Paterson RG, Wen X, Lamb RA, Jardetzky TS. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci USA 2005; 102: 9288– 9293 [CrossRef] [PubMed]
    [Google Scholar]
  16. Streltsov VA, Pilling P, Barrett S, McKimm-Breschkin JL. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN). Antiviral Res 2015; 123: 216– 223 [CrossRef] [PubMed]
    [Google Scholar]
  17. Coelingh KVW, Tierney EL. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. J Virol 1989; 63: 375– 382 [PubMed]
    [Google Scholar]
  18. Coelingh KVW, Winter CC, Jorgensen ED, Murphy BR. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. J Virol 1987; 61: 1473– 1477 [PubMed]
    [Google Scholar]
  19. Mizuta K, Tsukagoshi H, Ikeda T, Aoki Y, Abiko C et al. Molecular evolution of the haemagglutinin-neuraminidase gene in human parainfluenza virus type 3 isolates from children with acute respiratory illness in Yamagata prefecture, Japan. J Med Microbiol 2014; 63: 570– 577 [CrossRef] [PubMed]
    [Google Scholar]
  20. Coelingh KVW, Winter CC, Murphy BR. Nucleotide and deduced amino acid sequences of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957–1983. Virology 1988; 163: 137– 143 [Crossref]
    [Google Scholar]
  21. Villaran MV, García J, Gomez J, Arango AE, Gonzales M et al. Human parainfluenza virus in patients with influenza-like illness from central and South America during 2006–2010. Influenza Other Respir Viruses 2014; 8: 217– 227 [CrossRef] [PubMed]
    [Google Scholar]
  22. Almajhdi FN. Hemagglutinin-neuraminidase gene sequence-based reclassification of human parainfluenza virus 3 variants. Intervirology 2015; 58: 35– 40 [CrossRef] [PubMed]
    [Google Scholar]
  23. Godoy C, Peremiquel-Trillas P, Andrés C, Gimferrer L, Uriona SM et al. A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain. Diagn Microbiol Infect Dis 2016; 86: 153– 159 [Crossref]
    [Google Scholar]
  24. Prinoski K, Côté MJ, Kang CY, Dimock K. Evolution of the fusion protein gene of human parainfluenza virus 3. Virus Res 1992; 22: 55– 69 [CrossRef] [PubMed]
    [Google Scholar]
  25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156– 159 [CrossRef] [PubMed]
    [Google Scholar]
  26. Kosutic-Gulija T, Forcic D, Santak M, Ramljak A, Mateljak-Lukacevic S et al. Genetic heterogeneity of L-Zagreb mumps virus vaccine strain. Virol J 2008; 5: 79 [CrossRef] [PubMed]
    [Google Scholar]
  27. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673– 4680 [CrossRef] [PubMed]
    [Google Scholar]
  28. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods 2012; 9: 772 [CrossRef] [PubMed]
    [Google Scholar]
  29. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013; 30: 2725– 2729 [CrossRef] [PubMed]
    [Google Scholar]
  30. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 2012; 29: 1969– 1973 [CrossRef] [PubMed]
    [Google Scholar]
  31. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009; 25: 1451– 1452 [CrossRef] [PubMed]
    [Google Scholar]
  32. Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 2013; 32: 1478– 1488 [CrossRef] [PubMed]
    [Google Scholar]
  33. Palermo LM, Porotto M, Greengard O, Moscona A. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II. J Virol 2007; 81: 9152– 9161 [CrossRef] [PubMed]
    [Google Scholar]
  34. Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC et al. Seasonal trends of human parainfluenza viral infections: United States, 1990–2004. Clin Infect Dis 2006; 43: 1016– 1022 [CrossRef] [PubMed]
    [Google Scholar]
  35. Counihan ME, Shay DK, Holman RC, Lowther SA, Anderson LJ. Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J 2001; 20: 646– 653 [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000459
Loading
/content/journal/jmm/10.1099/jmm.0.000459
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error